Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7239
pubmed:dateCreated
2009-4-10
pubmed:abstractText
The clinical development of an inhibitor of cellular proteasome function suggests that compounds targeting other components of the ubiquitin-proteasome system might prove useful for the treatment of human malignancies. NEDD8-activating enzyme (NAE) is an essential component of the NEDD8 conjugation pathway that controls the activity of the cullin-RING subtype of ubiquitin ligases, thereby regulating the turnover of a subset of proteins upstream of the proteasome. Substrates of cullin-RING ligases have important roles in cellular processes associated with cancer cell growth and survival pathways. Here we describe MLN4924, a potent and selective inhibitor of NAE. MLN4924 disrupts cullin-RING ligase-mediated protein turnover leading to apoptotic death in human tumour cells by a new mechanism of action, the deregulation of S-phase DNA synthesis. MLN4924 suppressed the growth of human tumour xenografts in mice at compound exposures that were well tolerated. Our data suggest that NAE inhibitors may hold promise for the treatment of cancer.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1476-4687
pubmed:author
pubmed-author:AdhikariSharmilaS, pubmed-author:BergerAllison JAJ, pubmed-author:BolenJoseph BJB, pubmed-author:BrownellJames EJE, pubmed-author:BurkeKristine EKE, pubmed-author:CardinDavid PDP, pubmed-author:ClaiborneChristopher FCF, pubmed-author:CritchleyStephenS, pubmed-author:CullisCourtney ACA, pubmed-author:DickLawrence RLR, pubmed-author:DoucetteAmandaA, pubmed-author:GarnseyJames JJJ, pubmed-author:GaulinJeffrey LJL, pubmed-author:GavinJames MJM, pubmed-author:GershmanRachel ERE, pubmed-author:LangstonSteven PSP, pubmed-author:LaxYY, pubmed-author:LublinskyAnna RAR, pubmed-author:McDonaldAliceA, pubmed-author:MilhollenMichael AMA, pubmed-author:MizutaniHirotakeH, pubmed-author:NarayananUshaU, pubmed-author:OlhavaEdward JEJ, pubmed-author:PelusoStephaneS, pubmed-author:RezaeiMansourehM, pubmed-author:RolfeMarkM, pubmed-author:SintchakMichael DMD, pubmed-author:SmithPeter GPG, pubmed-author:SoucyTeresa ATA, pubmed-author:TalrejaTinaT, pubmed-author:ThomasMichael PMP, pubmed-author:TraoreTaryT, pubmed-author:VyskocilStepanS, pubmed-author:WeatherheadGabriel SGS, pubmed-author:ZhangJulieJ
pubmed:issnType
Electronic
pubmed:day
9
pubmed:volume
458
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
732-6
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.
pubmed:affiliation
Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, USA. teresa.soucy@mpi.com
pubmed:publicationType
Journal Article